MedTrace Logo

CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI)

NCT01076036 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2015-09-07

Study results available
· View outcomes & findings →

Summary

An open-label, prospective, single-arm study is designed to evaluate safety, clinical and technical efficacy of the CorPath 200 System in delivery and manipulation of the coronary guide wires and balloon/stent systems for use in robotically-assisted, percutaneous coronary intervention (PCI) procedures.

Conditions

Interventions

DEVICE

CorPath 200

CorPath™ 200 robotically-assisted percutaneous coronary intervention

DEVICE

CorPath 200

CorPath PCI - robotic-assisted percutaneous coronary intervention

Sponsors & Collaborators

  • Corindus Inc.

    lead INDUSTRY

Principal Investigators

  • Juan F Granada, MD · CORBIC and CRF

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076036 on ClinicalTrials.gov